Centene Gross Profit 2012-2026 | CNC
Centene annual/quarterly gross profit history and growth rate from 2012 to 2026. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.
- Centene gross profit for the quarter ending March 31, 2026 was $5.558B, a 6.84% increase year-over-year.
- Centene gross profit for the twelve months ending March 31, 2026 was $14.223B, a 18.19% decline year-over-year.
- Centene annual gross profit for 2025 was $194.777B, a 1057.39% increase from 2024.
- Centene annual gross profit for 2024 was $16.829B, a 2.81% decline from 2023.
- Centene annual gross profit for 2023 was $17.315B, a 3.96% increase from 2022.
|
Centene Annual Gross Profit (Millions of US $) |
|
|---|---|
| 2025 | $194,777 |
| 2024 | $16,829 |
| 2023 | $17,315 |
| 2022 | $16,656 |
| 2021 | $14,199 |
| 2020 | $15,216 |
| 2019 | $8,843 |
| 2018 | $8,421 |
| 2017 | $5,801 |
| 2016 | $5,544 |
| 2015 | $2,746 |
| 2014 | $1,904 |
| 2013 | $1,208 |
| 2012 | $813 |
| 2011 | $782 |
|
Centene Quarterly Gross Profit (Millions of US $) |
|
|---|---|
| 2026-03-31 | $5,558 |
| 2025-12-31 | $2,467 |
| 2025-09-30 | $3,251 |
| 2025-06-30 | $2,947 |
| 2025-03-31 | $5,202 |
| 2024-12-31 | $3,720 |
| 2024-09-30 | $4,035 |
| 2024-06-30 | $4,429 |
| 2024-03-31 | $4,645 |
| 2023-12-31 | $3,660 |
| 2023-09-30 | $4,551 |
| 2023-06-30 | $4,530 |
| 2023-03-31 | $4,574 |
| 2022-12-31 | $3,847 |
| 2022-09-30 | $3,972 |
| 2022-06-30 | $4,484 |
| 2022-03-31 | $4,353 |
| 2021-12-31 | $3,634 |
| 2021-09-30 | $3,656 |
| 2021-06-30 | $3,293 |
| 2021-03-31 | $3,616 |
| 2020-12-31 | $3,304 |
| 2020-09-30 | $3,908 |
| 2020-06-30 | $4,849 |
| 2020-03-31 | $3,155 |
| 2019-12-31 | $2,074 |
| 2019-09-30 | $2,129 |
| 2019-06-30 | $2,281 |
| 2019-03-31 | $2,359 |
| 2018-12-31 | $2,183 |
| 2018-09-30 | $2,218 |
| 2018-06-30 | $1,954 |
| 2018-03-31 | $2,066 |
| 2017-12-31 | $1,480 |
| 2017-09-30 | $1,408 |
| 2017-06-30 | $1,542 |
| 2017-03-31 | $1,371 |
| 2016-12-31 | $1,766 |
| 2016-09-30 | $1,454 |
| 2016-06-30 | $1,499 |
| 2016-03-31 | $825 |
| 2015-12-31 | $791 |
| 2015-09-30 | $701 |
| 2015-06-30 | $667 |
| 2015-03-31 | $587 |
| 2014-12-31 | $588 |
| 2014-09-30 | $474 |
| 2014-06-30 | $445 |
| 2014-03-31 | $397 |
| 2013-12-31 | $340 |
| 2013-09-30 | $333 |
| 2013-06-30 | $292 |
| 2013-03-31 | $243 |
| 2012-12-31 | $313 |
| 2012-09-30 | $153 |
| 2012-06-30 | $149 |
| 2012-03-31 | $197 |
| 2011-12-31 | $212 |
| 2011-09-30 | $191 |
| 2011-06-30 | $198 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Health Maintenance Organizations | $18.343B | $194.777B |
| Centene Corporation is a well-diversified, multi-national healthcare company that primarily provides a set of services to government sponsored healthcare programs. The company serves the under-insured and uninsured individuals through member-focused services. It is also engaged in providing education and outreach programs to inform and assist members in accessing quality, appropriate healthcare services. Through a diversified product portfolio and expanding geographic reach, Centene continues to deliver results by growing premium and service revenues profitably. The company operates in two segments: Managed Care and Specialty Services. Managed Care - This segment provides health plan coverage to individuals through Government subsidized programs, including Medicaid. Specialty Services - This segment consists of its specialty companies offering diversified healthcare services and products to state programs, correctional facilities, healthcare organizations, employer groups and other commercial organizations. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UnitedHealth Group (UNH) | United States | $276.233B | 18.66 |
| Cigna Group (CI) | United States | $71.482B | 9.09 |
| Humana (HUM) | United States | $23.068B | 11.22 |
| Molina Healthcare (MOH) | United States | $7.599B | 13.70 |
| Select Medical Holdings (SEM) | United States | $2.030B | 14.23 |
| Joint (JYNT) | United States | $0.125B | 0.00 |
| Aethlon Medical (AEMD) | United States | $0.003B | 0.00 |